DE261516C - - Google Patents
Info
- Publication number
- DE261516C DE261516C DENDAT261516D DE261516DA DE261516C DE 261516 C DE261516 C DE 261516C DE NDAT261516 D DENDAT261516 D DE NDAT261516D DE 261516D A DE261516D A DE 261516DA DE 261516 C DE261516 C DE 261516C
- Authority
- DE
- Germany
- Prior art keywords
- trypanosomes
- preparation
- agglutinating
- blood cells
- saline solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004369 blood Anatomy 0.000 claims description 11
- 239000008280 blood Substances 0.000 claims description 11
- 230000003053 immunization Effects 0.000 claims description 9
- 230000004523 agglutinating effect Effects 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- 238000002649 immunization Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 210000000601 blood cell Anatomy 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 244000045947 parasite Species 0.000 claims description 2
- 241000700159 Rattus Species 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- 239000007788 liquid Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241000031711 Cytophagaceae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000004201 immune sera Anatomy 0.000 description 1
- 229940042743 immune sera Drugs 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/005—Trypanosoma antigens
Landscapes
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE261516C true DE261516C (cg-RX-API-DMAC7.html) |
Family
ID=519071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT261516D Active DE261516C (cg-RX-API-DMAC7.html) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE261516C (cg-RX-API-DMAC7.html) |
-
0
- DE DENDAT261516D patent/DE261516C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wheeler et al. | Uptake of glycine by natural phytoplankton communities | |
| EP1124575B1 (de) | Verfahren zur herstellung eines antiviralen mittels | |
| DE2403994A1 (de) | Herstellung von antisera | |
| DE261516C (cg-RX-API-DMAC7.html) | ||
| WO1988000835A1 (en) | Production and use of anthelmintic agents and protective antigens | |
| DE2836362A1 (de) | Diagnostisches mittel | |
| Gosner | Systematic variations in tadpole teeth with notes on food | |
| DE1617605C3 (de) | Verfahren zum Herstellen eines Pertussis-Antigens | |
| DE3135599A1 (de) | An menschliche fibroblastenzellen adaptierte hepatitis-a-viren | |
| DE60118409T2 (de) | Herstellungsverfahren von immunglobulinen, die gegen menschliche thymozyten gerichtet sind | |
| DE3402492A1 (de) | Antigene parasitischer wuermer sowie ihre herstellung und verwendung | |
| DD283330A5 (de) | Zepareth-herstellungsverfahren aus selektierten zellinien begrenzter vermehrungspotenz (finit lines) | |
| DE2728802C2 (de) | Verfahren zum Herstellen eines antischistosomen immunologischen Mittels | |
| DE2644149C3 (de) | Neue Parasiten-Antigene | |
| DE1278075B (de) | Verwendung von Gewebekulturen zur Zuechtung von Viren fuer die Gewinnung von Impfstoffen | |
| Bang | A survey of phagocytosis as a protective mechanism against disease among invertebrates | |
| DE3006289C2 (de) | Adsorbens für den passiven Agglutinationstest | |
| DE2162013C3 (de) | Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut | |
| DE435691C (de) | Verfahren zur Gewinnung der Stoffwechselprodukte von Mikroorganismen | |
| AT54778B (de) | Verfahren zur Gewinnung von Immunstoffen. | |
| DE2951412A1 (de) | Verfahren zur herstellung immunologisch reaktiver praeparate | |
| DE525949C (de) | Verfahren zur Zuechtung von im Menschen- und Tierkoerper parasitisch vegetierenden Kleinlebewesen | |
| DE2132911C2 (de) | Verfahren zum Herstellen eines stark abgeschwächte Rötelviren enthaltenden Impfstoffs | |
| DE2101866A1 (de) | Verfahren zum Reinigen von Orgotein | |
| DE2102245A1 (de) | Verfahren zur Herstellung von Antisera |